Advanced Oncotherapy (AVO) – Posting of Circular, Notice of General Meeting and Update on Financing Options

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a circular containing a Notice of General Meeting has been posted to Shareholders. The purpose of the Circular is to explain the background to the proposed Equity Financing Facility with Bracknor announced on 22 February 2017 and why the […]

Advanced Oncotherapy (AVO) secures of £24m financing for Harley Street

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has signed an agreement with a fund advised by Metric Capital Partners LLP, a pan-European private capital fund manager, whereby Metric Capital will invest £24 million in a financing facility to support the Company’s provision of vendor financing for the […]